Fiche centre
Haukeland University Hospital
Bergen — Norway
Essais liés7clinical trials
VilleBergenlocalisation
PaysNorwaylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06685848
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PETRA-NMD — Personalized Training for People With Rare Neuromuscular Disorders | Myopathies | Non applicable | NCT06708468 | PETRA-NMD — Personalized Training for People With Rare Neuromuscular Disorders | RECRUITING |
| Hemanext ONE system | Cancer | Non applicable | NCT06685848 | Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion | ACTIVE_NOT_RECRUITING |
| Nipocalimab | Lupus | Phase 3 | NCT07438496 | GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING |
| Atorvastatin 40mg | Migraine | Phase 2 | NCT06248671 | EStatinMig — Prophylactic Treatment With Atorvastatin for Episodic Migraine. | RECRUITING |
| Atorvastatin 40mg | Migraine | Phase 2 | NCT06485336 | Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig) | RECRUITING |
| N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease | Alzheimer | Phase 2 | NCT07741071 | N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease | NOT_YET_RECRUITING |
| SOUL-DM1 — Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 | Myopathies | À vérifier | NCT05006924 | SOUL-DM1 — Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 | COMPLETED |